Release Date: 10/03/20 08:17 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 487.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%